Literature DB >> 21895402

Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer.

L R Yu1, J Q Lv, L Y Jin, S D Ding, X Y Ma, J J Wang, X Q Zhu.   

Abstract

Protein kinase C was found to be significantly over-expressed in cancer samples compared to adjacent normal cervical tissues by proteomics in our previous study. The aim of this study was to examine protein kinase C expression and to analyze the expression patterns of protein kinase C isoforms in squamous cervical cancer at the protein levels and their associations with clinical and pathologic factors of squamous cervical cancer. First, Western blotting was used to examine protein kinase C expression in the specimens of tumors and matched adjacent normal tissues which were collected from 12 patients with squamous cervical cancer. Protein kinase C isoforms (α, δ, θ and ζ) expression were then detected by immunohistochemistry in other 43 cases of squamous cervical cancer tissues, 32 cases of corresponding adjacent normal cervical squamous epithelial tissue and 31 cases of cervical intraepithelial neoplasia. Western blot analysis revealed that protein kinase C expression was positive in squamous cervical cancer while it was not expressed in normal cervical tissues. On the other hand, immunohistochemical analysis suggested that, protein kinase C isoforms (α, δ, θ and ζ) expression was significantly higher in squamous cervical cancer compared to cervical intraepithelial neoplasia, as well as in cervical intraepithelial neoplasia compared with normal tissues, respectively.High levels of protein kinase C α expression were associated with cellular differentiation(P<0.05). Protein kinase C δ was significantly associated with tumor stage (P<0.05) and protein kinase C ζ was associated with lymphatic metastasis (P < 0.05). These findings indicate that protein kinase C isoforms expression in cervical lesions was associated with carcinogenesis and might play important roles throughout the process of cervical cancer development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895402

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

Review 1.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

2.  Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

Authors:  S Yao; S J Ireland; A Bee; C Beesley; S S Forootan; A Dodson; T Dickinson; P Gerard; L-Y Lian; J M Risk; P Smith; M I Malki; Y Ke; C S Cooper; C Gosden; C S Foster
Journal:  Br J Cancer       Date:  2012-05-29       Impact factor: 7.640

3.  Atypical protein kinase C zeta: potential player in cell survival and cell migration of ovarian cancer.

Authors:  Kelly K Y Seto; Irene L Andrulis
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.